YOLFTbeta
60

Ningbo Menovo Pharm Co Ltd

603538 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

20.51CNY-0.84 (-3.93%)

Price History

Full chart

Market Stats

Previous Close21.35
Open21.49
Day Range20.48 – 21.49
52-Week Range18.97 – 70.39
Volume19.09M
Market Cap9.72B
P/E (TTM)75.24
Forward P/E0.00
EPS0.38
Dividend Yield0.54%
Beta-0.17
50-Day Avg27.61
200-Day Avg26.02

About

Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. The company's products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium, purin bahrain, and other products. It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous system, gastrointestinal tract, and other therapeutic areas. The company was founded in 2004 and is headquartered in Ningbo, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Cheng Zhi Yao
  • Employees2.37K
  • HeadquartersBuilding 1, Ningbo R&D Park, Ningbo, China, 315048, China
  • Websitehttps://www.menovopharm.com

Leadership

  • Mr. Cheng Zhi YaoGM & Chairman · b. 1974
  • Mr. Gaofeng YingCFO, Board Secretary, Accounting Supervisor & Director · b. 1971
  • Mr. Jian XuDeputy General Manager · b. 1968

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue490.24M486.65M501.73M636.30M597.17M578.09M605.32M848.96M1.18B1.19B1.26B1.46B1.22B1.37B1.50B
Growth (%)--0.73%+3.10%+26.82%-6.15%-3.19%+4.71%+40.25%+39.02%+1.12%+5.43%+15.80%-16.51%+12.85%+9.49%
Cost of Revenue331.59M326.44M329.85M428.07M407.86M371.84M399.07M578.00M739.54M792.02M792.22M890.82M873.79M951.57M976.42M
Gross Profit158.65M160.21M171.87M208.24M189.31M206.24M206.26M270.96M440.67M401.35M465.93M566.16M342.71M421.28M526.71M
Gross Margin32.36%32.92%34.26%32.73%31.70%35.68%34.07%31.92%37.34%33.63%37.03%38.86%28.17%30.69%35.04%
Operating Expense66.47M81.19M87.07M116.63M97.80M107.63M142.37M158.40M250.93M195.60M278.02M160.84M323.96M328.69M326.00M
Operating Income92.19M79.03M84.81M91.61M91.50M98.62M63.88M112.56M189.73M205.75M187.91M405.32M18.75M92.59M200.71M
Operating Margin18.80%16.24%16.90%14.40%15.32%17.06%10.55%13.26%16.08%17.24%14.94%27.82%1.54%6.74%13.35%
EBITDA82.82M85.59M99.45M128.49M132.58M140.12M101.17M176.23M275.58M318.66M306.89M510.54M151.55M265.65M307.19M
EBITDA Margin16.89%17.59%19.82%20.19%22.20%24.24%16.71%20.76%23.35%26.70%24.39%35.04%12.46%19.35%20.44%
Net Income69.33M60.61M69.01M72.73M77.02M78.84M44.68M96.35M150.90M155.96M142.53M338.86M11.59M66.81M102.23M
Net Income Margin14.14%12.45%13.75%11.43%12.90%13.64%7.38%11.35%12.79%13.07%11.33%23.26%0.95%4.87%6.80%
R&D23.29M25.98M22.60M30.55M38.12M31.58M32.02M39.21M52.96M73.73M88.31M98.16M95.30M99.65M109.35M
R&D as % of Total Revenue4.75%5.34%4.51%4.80%6.38%5.46%5.29%4.62%4.49%6.18%7.02%6.74%7.83%7.26%7.27%
Interest Expense3.85M008.37M1.94M2.97M4.39M19.62M24.65M26.20M27.66M28.06M29.98M49.13M41.83M
Interest Expense % of Total Revenue0.79%0.00%0.00%1.31%0.32%0.51%0.73%2.31%2.09%2.20%2.20%1.93%2.46%3.58%2.78%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets709.97M831.58M864.69M966.89M827.64M955.29M1.51B2.27B2.61B3.06B4.00B4.42B4.42B4.65B4.85B
Total Liabilities331.50M389.00M377.24M402.54M181.83M224.27M351.19M930.92M1.05B1.30B2.02B2.25B2.24B2.36B2.40B
Total Equity362.20M423.73M463.94M535.04M611.16M690.08M1.12B1.20B1.36B1.55B1.75B2.08B2.10B2.19B2.34B
Cash128.50M63.74M119.47M185.05M99.55M125.16M258.55M369.95M342.26M235.67M421.79M791.94M456.04M585.43M701.67M
Total Debt132.96M202.37M164.65M159.00M30.00M67.00M155.03M535.86M596.08M757.42M1.26B1.20B1.30B1.14B-
Net Debt4.46M138.63M45.18M-26.05M-69.55M-58.16M-103.52M165.91M253.82M521.75M838.59M410.66M790.33M557.59M674.40M

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow121.67M38.11M149.21M75.22M133.42M117.24M80.15M46.60M179.75M251.61M220.63M276.95M9.13M97.54M157.56M
Investing Cash Flow-245.68M-131.38M-30.11M-11.46M-59.02M-116.86M-421.59M-326.21M-351.20M-478.96M-603.25M50.26M-323.61M-99.79M-
Financing Cash Flow44.26M51.55M-75.64M-15.69M-135.43M32.89M471.17M384.00M99.00M138.44M583.15M-178.46M54.87M32.39M-
Capital Expenditure159.71M81.72M75.44M46.14M61.56M108.84M86.22M299.59M328.07M311.74M529.89M571.62M219.54M179.40M112.08M
Free Cash Flow-159.71M-43.62M73.77M29.07M71.86M8.40M-6.06M-252.99M-148.32M-60.13M-309.26M-294.67M-210.41M-81.87M45.48M
Dividends Paid10.54M10.73M27.71M10.04M1.83M2.65M4.36M39.06M29.81M16.44M13.83M30.26M59.24M22.71M25.89M
FCF to OCF-131.27%-114.47%49.44%38.66%53.86%7.17%-7.57%-542.96%-82.51%-23.90%-140.17%-106.40%-2303.83%-83.93%28.87%
Dividend Paid to FCF-6.60%-24.59%37.56%34.53%2.55%31.51%-71.93%-15.44%-20.10%-27.35%-4.47%-10.27%-28.16%-27.74%56.93%

Earnings

Report DateAug 21, 2017Oct 25, 2017Dec 31, 2017Apr 24, 2018Jul 24, 2018Oct 24, 2018Dec 31, 2018Apr 16, 2019Jul 29, 2019Oct 23, 2019Dec 31, 2019Apr 20, 2020Jul 30, 2020Oct 22, 2020Apr 20, 2021Jul 26, 2021Oct 27, 2021Apr 25, 2022Aug 15, 2022Oct 27, 2022Apr 3, 2023
EPS Estimate---------------------
EPS Actual0.100.010.050.040.180.100.150.210.210.190.110.290.310.170.170.280.090.540.320.130.53
Surprise---------------------
TimingPre-marketPre-market-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketPre-market-After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap9.72B
Enterprise Value9.58B
Trailing P/E75.24
Forward P/E0.00
Price / Sales5.77
Price / Book3.22
EPS0.38
Book Value8.63
Revenue (TTM)1.68B
Gross Profit (TTM)525.10M
EBITDA316.99M
Profit Margin6.94%
Operating Margin13.36%
Return on Equity4.41%
Return on Assets2.42%
Shares Outstanding339.93M
Shares Float253.94M
Beta-0.17
Dividend Yield0.54%
Dividend Rate0.16
Payout Ratio0.00%

Dividends

20231×
0.17May 26, 2023
20221×
0.20Jun 8, 2022
20201×
0.08Jun 29, 2020
20191×
0.14Aug 6, 2019
20181×
0.13Jul 9, 2018

Stock Splits

  • Jun 8, 20221594:1141
  • Jul 9, 20186:5